Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?

出版年份 2016 全文链接

标题

作者

关键词

PCSK9, LDL-C, LDL-receptor, VLDL, PCSK9-Centric lipid lowering, Pleiotropic, Monoclonal antibody, CRISPR-CAS9, Anti-sense oligonucleotide, Peptide-mimetic, Adnectin, Vaccine, Lipoprotein-apheresis

出版物

ATHEROSCLEROSIS

Volume 248, Issue -, Pages 62-75

出版商

Elsevier BV

发表日期

2016-03-10

DOI

10.1016/j.atherosclerosis.2016.02.018

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started